Today’s AI Top Pick: ZTS

8/10/2026 · Model Aligned screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured daily model accuracy · ZTS72%314 resolved forecasts · 45d window · verify →

View the live ZTS price forecast →

Today's pick · Model AlignedZTSBUY NOW8.6 / 108/10/2026

Zoetis (ZTS) is the cleanest setup in the pool: it matches the screen (bullish_prob 1.0, near_term_bullish 1.0) AND every Kronos horizon points up on every timeframe — 1h fc_long +7.03%, 4h fc_mid +23.75% / fc_long +41.14%, 1d fc_mid +57.27% / fc_long +66.27%, and 1wk fc_short +60.12% / fc_long +133.39%. That's the rare 1h+4h+1d+1wk quadruple confluence the screen is designed to surface, and it's paired with washed-out positioning: pos_in_21bar_range is 15% (1h), 7% (4h), 8% (1d), and just 0.91% on the weekly with a -39.6% weekly drawdown. This is a name pinned to the floor, not one being chased. The fundamentals do the heavy lifting on the 'why is it this cheap' question. ZTS trades at PE 11.95 / fwdPe 10.76 with a 64.4% ROE, 37.7% operating margin, and 27.5% profit margin — animal-health economics that historically commanded a 25-30x multiple. Perf YTD -42% and perfYear -51% reflect the leadership-shift/competitive-pressure narrative in the Q2 headlines, but there is no guidance cut, no legal action, no dilution — just sentiment purge. Sell-side still carries a 2.1 recom and 32.3% target upside. Fundamental_score 6.5. Contrast this with the other top-of-list names: LII is technically the strongest screen match but the 2026 EPS guidance cut on 7/31 (stock down 22.4%) is exactly the landmine the instructions warn about — I'm demoting it. CHRW's weekly forecast is deeply negative (-45% long). CSGP shows monster forecasts but sits at 97.5% of its daily range — chasing. DECK is the only other clean quadruple-confluence bullish name and it's the #2 pick, but forecast magnitudes (+11% long on 1h/1d) are a fraction of ZTS's. Entering today is right because ZTS is at 73.10, right off multi-year lows with the entire forecast surface pointing up and no bad-news catalyst hanging over it. Waiting risks missing the mean-reversion bounce that the 1wk fc_short of +60% is implying, and downside is limited by the fact that the stock is already at 0.91% of its 21-week range.

ZTS forecast chart
Entry zone
72.50 - 74.00 (start today at 73.10, add on any dip toward 71)
Stop loss
67.90 (below recent 21-bar low; ~7% risk)
First target
82.00 (+12%, reclaim of prior consolidation)
Longer target
95-100 (+30-37%, aligns with 4h fc_long +41% and analyst target upside +32%)
Risks
  • PerfYear -51% signals the market is pricing a fundamental competitive threat (GLP-1 pet analogues / Elanco parasiticide competition) — a further guidance cut on the next print could break 68 support
  • Debt/Equity 2.93 is elevated for a healthcare name — leaves less cushion if margins compress from the 37.65% operating level
  • Bullish thesis is essentially a mean-reversion bet after a -50% year; if animal-health sector rating gets re-based lower, fwdPe 10.76 could still compress to 8x
  • Kronos 1wk fc_long of +133% is almost certainly overstated at that magnitude — treat as directional signal, not literal target
  • Recent Q2 headlines cited 'leadership shifts and competitive pressures' — narrative overhang could delay the bounce even if numbers are fine
Honorable mentions
DECKThe other clean quadruple-confluence name (bullish_prob 1.0, near_term 1.0, all TFs positive). FwdPe 11.66, ROE 42.6%, no bad news. Positioned at 12-20% of range with -14% weekly drawdown. Forecast magnitudes smaller than ZTS (+11-16% on longer horizons) which is why it's #2, but a safer, less-controversial thesis.
CHRWMatches screen (bullish_prob 1.0), oversold RSI 32.15, and 1h/4h forecasts positive with 4h fc_mid +22.7%. Analyst recom 1.89 and target upside 35.7%. Demoted because the 1wk forecast is aggressively negative (-45% fc_long), signaling this is a bounce trade only, not a swing hold.
Full ranking (13)
#SymbolVerdictScoreRead
1ZTSBUY NOW8.6Quadruple-timeframe bullish confluence at 0.91% of weekly range with 10.76 fwdPe and no landmine news — the trade of the pool.
2DECKBUY NOW7.2Clean all-TF bullish, fwdPe 11.66, ROE 42.6%, low in range, no negative catalyst — safest full-conviction alt to ZTS.
3CHRWBUY PULLBACK6.0Oversold (RSI 32) with strong 1h/4h forecasts but weekly forecast turns sharply negative — bounce trade only.
4WMTBUY PULLBACK5.6Bullish_prob 0.8 with positive short-mid forecasts, but 1wk fc_long -42% and Trump-pressure headline warrant patience.
5CSGPWAIT5.2Massive 1d/1wk forecasts (+108%/+162%) but sitting at 97.5% of daily range and PE 166 — chase risk too high.
6LIIAVOID4.8Best screen match on paper, but 7/31 EPS guidance cut and -22% drop is the exact landmine to skip despite bullish forecasts.
7NVMIWAIT4.5Fundamental_score 8 and analyst support strong, but near_term_bullish 0.2 and 1wk fc_long -64% signal wait.
8TRAC-USDBUY PULLBACK4.2Bullish_prob 1.0 with 1wk fc_long +126% and washed-out position, but low-cap crypto with thin narrative.
9INODWAIT3.9Bullish_prob 0.8 but 1d/1wk long forecasts negative and 'fully valued' headline — no edge here.
10DYWAIT3.6Fundamental_score 8 but bullish_prob 0 and 1wk fc_long -66.9% — model is not aligned with the screen.
11PYTH-USDAVOID3.4At 100% of 4h range, near_term_bullish 0, and a coincodex drop-to-$0.03 call — nothing to like today.
12POWLAVOID3.2Perf YTD +99% and 'Bull Trap Over' headline with bullish_prob 0 and 1wk fc_long -82% — top of cycle.
13DTMAVOID2.8Bullish_prob 0, pos_in_range 0% on 4h/1d/1wk (broken), and 1wk fc_long -44% — capitulating, not bottoming.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.